Related Experiment Video
Updated: Jun 2, 2026
09:03
Modified In Vivo Matrix Gel Plug Assay for Angiogenesis Studies
Published on: June 30, 2023
Toll-like receptors in angiogenesis
Karsten Grote1, Harald Schütt, Bernhard Schieffer
1Cardiology and Angiology, Hannover Medical School, Hannover, Germany. grote.karsten@mh-hannover.de
Thescientificworldjournal
|April 26, 2011
Summary
Toll-like receptors (TLRs) activate immune responses and promote blood vessel growth (angiogenesis) in both health and disease. Understanding TLRs offers new therapeutic strategies for inflammatory conditions and cardiovascular diseases.
Area of Science:
- Immunology
- Molecular Biology
- Pathology
Background:
- Toll-like receptors (TLRs) are pattern-recognition receptors crucial for initiating innate and adaptive immune responses against microbial pathogens.
- TLR expression extends beyond immune cells to various tissues, recognizing both microbial and host-derived molecules.
- Dysregulated TLR signaling is implicated in chronic inflammatory disorders, cardiovascular diseases, and cancer, often linked to inflammation-induced angiogenesis.
Purpose of the Study:
- To review the role of Toll-like receptors (TLRs) in promoting angiogenesis during physiological and pathophysiological processes.
- To explore the evidence linking TLR activation to angiogenesis in response to both exogenous and endogenous ligands.
- To discuss the potential clinical relevance of TLR modulation for novel therapeutic strategies.
Main Methods:
- Literature review of studies investigating Toll-like receptors (TLRs) and angiogenesis.
- Analysis of research on TLR involvement in inflammatory and cardiovascular diseases.
- Synthesis of evidence regarding TLR activation by exogenous and endogenous ligands.
Main Results:
- Toll-like receptor (TLR) activation has been shown to promote angiogenesis in diverse inflammatory contexts.
- Both microbial (exogenous) and host-derived (endogenous) molecules can trigger TLR-mediated angiogenesis.
- The precise mechanisms by which TLRs influence angiogenesis remain under investigation.
Conclusions:
- Toll-like receptors (TLRs) play a significant role in angiogenesis, impacting both normal physiological processes and disease pathogenesis.
- Modulating TLR activity presents a promising avenue for developing new treatments for conditions characterized by aberrant angiogenesis.
- Further research is needed to fully elucidate the complex mechanisms of TLR-driven angiogenesis for targeted therapeutic interventions.
Related Concept Videos
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
01:10Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:26Receptor Tyrosine Kinases
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...